Press "Enter" to skip to content

Bayer reaps profit lift from Monsanto seeds, consumer health

Bayer’s $63 billion purchase of U.S. seeds maker Monsanto made its mark on the German company’s fourth quarter earnings on Wednesday, lifting profit and boding well for the peak season of its enlarged agriculture business.

Original source:

Also Read:   Bayer stresses drug's tolerability in bid for prostate cancer market